France· FR:62000612
AMIKACINE VIATRIS 50 mg/1 ml, solution injectable
A medicinal product containing sulfate d'amikacine, registered in France by VIATRIS SANTE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULFATE D'AMIKACINE
- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340095596641820 ampoule(s) en verre de 1 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sulfate d'amikacine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAMIKACIN B. BRAUNB. Braun Melsungen AG, Melsungen
- United KingdomAmikacin 2.5% eye drops preservative freeSpecial Order
- United Statesamikacin sulfateSagent Pharmaceuticals
- BelgiumAmikacine B. Braun 10 mg/mlB. Braun Melsungen
- PolandAmikacin AdamedAdamed Pharma S.A.
- ItalyAMIKACINA TEVATEVA ITALIA S.R.L.
- SpainAMICACINA B BRAUN 10 mg/ml SOLUCION PARA PERFUSION INTRAVENOSAB Braun Medical S.A.
- FinlandAmikacin Afortas2Care4 Generics ApS
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Amikacin B. Braun
- Belgium · Amikacine B. Braun, Amikacine Fresenius Kabi
- Bulgaria · Amikacin Kabi, Амикацин Б. Браун
- Cyprus · Amika-Synto, Amikacin Vioser
- Czechia · Amikacin B. Braun, Amikacin Fresenius Kabi
- Germany · Amikacin B. Braun, Amikacin Eberth
- Denmark · Amikacin Afortas, Amikacin Macure
- Estonia · Amikacin B. Braun
- Spain · Amicacina, Amicacina B. Braun
- Finland · Amikacin Afortas, Amikacin Macure
- United Kingdom (Northern Ireland) · Amikacin Demo Pharma Uk, Amikacin Galvany Pharma
- Greece · Amicasil, Amikacin Anfarm
- Croatia · Amikacin Zentiva
- Hungary · Amikacin Anfarm, Amikacin B. Braun
- Ireland · Amikacin, Amikacin Athlone Pharmaceuticals
- Iceland · Arikayce Liposomal
- Italy · Amicasil, Amikacina B. Braun
- Liechtenstein · Arikayce Liposomal
- Lithuania · Biodacyna
- Luxembourg · Amikacin B. Braun, Amukin
- Latvia · Amikacin B.Braun
- Malta · Amikacin Tillomed Laboratories, Uzix
- Netherlands · Amikacine Hospira
- Norway · Amikacin Afortas, Amikacin Macure
- Poland · Amikacin B. Braun, Amikacin Kabi,
- Portugal · Amicacina Hikma, Amicacina Kabi
- Romania · Amikacin Noridem, Amikacină Atb
- Sweden · Amikacin Afortas, Amikacin Fresenius Kabi
- Slovenia · Amikacin Kabi
- Slovakia · Amikacin B. Braun, Amikacin Fresenius Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/10694353-a36a-4045-aa9c-a330ad635df7 GET /v1/drugs/10694353-a36a-4045-aa9c-a330ad635df7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62000612",
"date_amm": "1996-05-20",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "SULFATE D'AMIKACINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intracérébroventriculaire;intramusculaire;intrathécale;intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about sulfate d'amikacine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.